Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Wang Xiaodong −$46.8M Director sold 100% of stake
  2. Lee Chan Henry −$865K SVP, General Counsel sold 100% of stake
  3. Ball Titus B. −$679K Principal Accounting Officer sold 100% of stake
  4. Wu Xiaobin −$106K President and COO sold 100% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-22 Yi Qingqing Director Grant or award +16,692 24,492
2022-06-22 Yi Qingqing Director Grant or award · Share Option (Right to Buy) −34,645 34,645
2022-06-21 Wang Lai Global Head of R&D Sale −723 $149.01 $108K 0
2022-06-21 Wu Xiaobin President, COO & GM China Sale −1,010 $144.36 $146K 0
2022-06-17 Wang Lai Global Head of R&D Sale −445 $139.40 $62K 723
2022-06-17 Wu Xiaobin President, COO & GM China Sale −578 $139.60 $81K 1,010
2022-06-17 Wang Julia Aijun Chief Financial Officer Sale −161 $136.64 $22K 0
2022-06-06 Wang Lai Global Head of R&D Sale −660 $142.00 $94K 0
2022-06-06 Wu Xiaobin President, COO & GM China Sale −3,410 $141.99 $484K 0
2022-05-17 Wang Lai Global Head of R&D Option exercise +233,948 $2.29 $536K 408,499
2022-05-17 Wang Lai Global Head of R&D Option exercise +999,999 $3.49 $3.5M 1,408,498
2022-05-17 Wang Lai Global Head of R&D Option exercise · Share Option (Right to Buy) −233,948 0
2022-05-17 Wang Lai Global Head of R&D Option exercise · Share Option (Right to Buy) −999,999 0
2022-05-05 Wu Xiaobin President, COO & GM China Sale −800 $161.72 $129K 5,925
2022-05-05 Wu Xiaobin President, COO & GM China Sale −3,350 $163.23 $547K 2,575
2022-05-05 Wu Xiaobin President, COO & GM China Sale −175 $165.02 $29K 2,400
2022-05-05 Wu Xiaobin President, COO & GM China Sale −1,100 $165.07 $182K 1,300
2022-05-05 Wu Xiaobin President, COO & GM China Sale −700 $167.32 $117K 600
2022-05-05 Wu Xiaobin President, COO & GM China Sale −100 $168.15 $17K 500
2022-05-05 Wu Xiaobin President, COO & GM China Sale −500 $169.39 $85K 0

Page 52 of 71 · 1,406 trades